(Q37905055)

25 August 2017

1 reference

title

New β-glucan inhibitors as antifungal drugs (English)

1 reference

25 August 2017

Richard F Hector

1

1 reference

25 August 2017

Donald E Bierer

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

25 July 2011

1 reference

Expert Opinion on Therapeutic Patents

25 August 2017

published in

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

10

1 reference

25 August 2017

page(s)

1597-1610

1 reference

Cell wall assembly in Saccharomyces cerevisiae

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Cell wall construction in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Deletion of the CaBIG1 gene reduces beta-1,6-glucan synthesis, filamentation, adhesion, and virulence in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Novel antifungal agents: Triazolopyridines as inhibitors of β-1,6-glucan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

1,3-Benzoxazole-4-carbonitrile as a novel antifungal scaffold of β-1,6-glucan synthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

Discovery and characterization of ß-1,6-glucan inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.603899

10.1517/13543776.2011.603899

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference